Legend Biotech Corp. (LEGN)
22.11
-0.21
(-0.94%)
USD |
NASDAQ |
Dec 15, 13:49
Legend Biotech Total Liabilities (Quarterly): 693.56M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| CorMedix, Inc. | 376.73M |
| Exelixis, Inc. | 662.85M |
| Abeona Therapeutics, Inc. | 59.86M |
| Akero Therapeutics, Inc. | 47.94M |
| Cabaletta Bio, Inc. | 50.29M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.713B |
| Shareholders Equity (Quarterly) | 1.011B |
| Debt to Equity Ratio | 0.4057 |
| Current Ratio | 2.865 |
| Net Debt Paydown Yield | -0.24% |